Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-02-23Clinical Trial Update: Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism? [Phase 4]
A Phase 4 trial evaluating low dose naltrexone for pain in fibromyalgia, investigating a central mechanism of action.
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia [Phase 2]
Phase 2 study evaluating droxidopa and droxidopa/carbidopa for potential clinical benefit in fibromyalgia has completed.
-
CLINICAL_TRIALS research · 2024-01-30Clinical Trial Update: The Effect of Minocycline and N-acetylcysteine for the Treatment of Fibromyalgia [Phase 1, Phase 2]
A Clinical Trial Update investigating minocycline and N-acetylcysteine for treatment of fibromyalgia across Phase 1 and Phase 2, with comple…
-
FDA approval · 2024-01-24FDA Approved: PREGABALIN — Supplemental Application (MARKSANS PHARMA LIMITED)
FDA approved a supplemental application for pregabalin submitted by Marksans Pharma Limited (ANDA 216197).
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Potential Role of Intravenous Lidocaine Versus Intravenous Ketamine for Pain Management in Fibromyalgia Patients [Phase 4]
Phase 4 clinical trial comparing intravenous lidocaine to intravenous ketamine for pain management in fibromyalgia patients is reported as a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-12-19FDA Approved: DULOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for duloxetine hydrochloride from Aurobindo Pharma Limited, granting regulatory clearance for a gene…
-
CLINICAL_TRIALS trial_result · 2023-12-15Clinical Trial Update: Analgesic Effect of Music Listening During Pain Elicitation in Fibromyalgia [NA]
A terminated clinical trial investigated whether music listening provides analgesic effects during pain elicitation in fibromyalgia, with re…
-
FDA approval · 2023-12-13FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) from Pfizer's Parke-Davis division.
-
FDA approval · 2023-12-13FDA Approved: LYRICA CR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for LYRICA CR (pregabalin) filed by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Micronized and Ultramicronized Palmitoylethanolamide in Fibromyalgia Patients [Phase 4]
Phase 4 clinical trial update studying micronized and ultramicronized palmitoylethanolamide in fibromyalgia patients has been completed.
-
FDA approval · 2023-08-18FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) from Allergan, Inc.
-
FDA approval · 2023-08-18FDA Approved: DRIZALMA SPRINKLE — Supplemental Application (SUN PHARMACEUTICAL INDUSTRIES, INC.)
The FDA approved Sun Pharmaceutical's supplemental NDA for Drizalma Sprinkle (duloxetine), adding a sprinkle-form formulation and related la…
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: "SMART-FM": Smart-Phone Based Digital Therapeutic for Management of Fibromyalgia [Phase 2]
Phase 2 trial update for SMART-FM, a smartphone-based digital therapeutic for fibromyalgia, with completed status and results posted in 2023…
-
FDA approval · 2023-07-21FDA Approved: PREGABALIN — Supplemental Application (Eskayef Pharmaceuticals Limited)
FDA approved a supplemental application for pregabalin (generic) submitted by Eskayef Pharmaceuticals Limited.
-
FDA approval · 2023-07-12FDA Approved: PREGABALIN — Original Application (Cadila Pharmaceuticals Limited)
FDA approved Cadila Pharmaceuticals Limited's original application for pregabalin, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Medical Cannabis for Treating Pain Related to Fibromyalgia [Phase 4]
Phase 4 clinical trial assessing medical cannabis for pain related to fibromyalgia has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome [Phase 4]
Phase 4 clinical trial update evaluating the efficacy and safety of Tongluo-Kaibi Tablet in patients with fibromyalgia syndrome.
-
FDA approval · 2023-06-26FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' supplemental application for pregabalin under ANDA 207623, indicating approval of changes to this gene…
-
FDA approval · 2023-06-21FDA Approved: PREGABALIN — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for pregabalin from Ascend Laboratories, LLC (ANDA207799), indicating approval of a supplemental fil…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Prospective Study to Evaluate a Digital Regimen for Fibromyalgia Management [Phase 3]
A Phase 3 prospective study evaluating a digital regimen for fibromyalgia management has completed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same i…
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Alembic Pharmaceuticals Inc.)
FDA approved a supplemental application for pregabalin from Alembic Pharmaceuticals Inc., enabling a generic version to be marketed.
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN — Supplemental Application (Dr.Reddys Laboratories Inc)
FDA approved a supplemental application for pregabalin from Dr. Reddy's Laboratories Inc., authorizing a generic version under the approved …
-
FDA approval · 2023-06-09FDA Approved: PREGABALIN CAPSULES, CV — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for Pregabalin Capsules, CV, enabling the marketing of a generic pregabalin capsule p…
-
CLINICAL_TRIALS trial_result · 2023-05-12Clinical Trial Update: e-Mobile Tablet for People With Chronic Conditions [NA]
Clinical trial update for an e-Mobile Tablet intervention in chronic conditions; the study is completed with results posted.